Most people agree that doing robust studies and pilots is important to the development of mobile and digital health, and to reaching the cost savings these technologies offer. But what kind of evidence is important? When is it time to stop running pilots and go to scale, and what challenges does that process offer? And furthermore, does every provider organization have to reinvent the wheel, or...
